Open Actively Recruiting

Evaluation of biomarkers for prediction of response to neoadjuvant treatment in HER2+ and triple negative breast cancer in pre- and post-menopausal women.

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
N/A

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
21-001050
Category
Breast Cancer
Location
  • UCLA Beverly Hills
  • UCLA Parkside
  • UCLA Santa Monica
  • UCLA Westwood